title: [Investigation on the role on perindopril for prevention and treatment of glucocorticoid-induced osteoporosis in rabbits].
abstract: OBJECTIVE
  To investigate the role of perindopril for prevention and treatment of glucocorticoid-induced osteoporosis (GIOP) in rabbits.
  
  
  METHODS
  A total of 45 male New Zealand white rabbits (10 months old, weight 3.0 to 3.5 kg) were randomly divided into 3 groups involving normal control group (muscle injection of saline solution, n = 15, group NC), model group (muscle injection of dexamethasone, n = 15, group GIOP), and treatment group (muscle injection of dexamethasone combined with oral perindopril, n = 15, group GIOP+ACEI). All rabbits put to death after 12 weeks' treatment. The changes of bone mass and strength were observed and analyzed by bone histomorphology, biomechanics, metabolic bone related serological indexes and mRNA expression.
  
  
  RESULTS
  At 12 weeks, the analysis of bone histomorphology and biomechanics results showed that the bone mass and bone strength of group GIOP were significantly lower than that of group NC (P < 0.05); after perindopril treatment, the bone mass and bone strength of group GIOP+ACEI were higher obviously than that of group GIOP (P < 0.05). Mineralizing surface,mineral apposition rate and serum osteocalcin in group GIOP decreased than group NC; however, osteoclast number, osteoclast surface, eroded surface, and urinary deoxypyridinoline in group GIOP increased than group NC (P < 0.05); these changes were inhibited after perindopril treatment (P < 0.05). Quantitative RT-PCR revealed that after dexamethasone treatment, the ratio of SOST mRNS expression and RANKL/OPG mRNA expression obviously increased than that of group NC (P < 0.05); and Runx2 expression decreased significantly (P < 0.05); while the changes of mRNA expression were improved by perindopril treatment.
  
  
  CONCLUSIONS
  Perindopril can promote bone formation and inhibit bone resorption to deduce glucocorticoid-induced osteoporosis. This study provides a new method for prevention and treatment of GIOP.
authors.forename: Feng
authors.initials: F
authors.lastname: Zhou
authors.forename: Chun
authors.initials: C
authors.lastname: Rong
authors.forename: Kai
authors.initials: K
authors.lastname: Wang
authors.forename: Chun-sheng
authors.initials: CS
authors.lastname: Wang
authors.forename: Yong-tao
authors.initials: YT
authors.lastname: Zhang
mesh_terms: D000818:Animals; D001696:Biomechanical Phenomena; D005938:Glucocorticoids / Q000009:adverse effects*; D008297:Male; D010024:Osteoporosis / Q000139:chemically induced / Q000517:prevention & control*; D020913:Perindopril / Q000627:therapeutic use*; D011817:Rabbits
chemical_list: D005938:Glucocorticoids; D020913:Perindopril